Loading insider details...
Beta
Latest Form 4 (Jul 22, 2026): Grant/Award of 10,826 QTTB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 22, 2026 | Q32 Bio Inc. (QTTB) | Grant/Award | 10,826 | n/a |
| Jan 31, 2026 | Q32 Bio Inc. (QTTB) | Grant/Award | 16,363 | $45.0K |
| Oct 28, 2025 | Q32 Bio Inc. (QTTB) | Grant/Award | 53,521 | n/a |
| Feb 27, 2025 | Q32 Bio Inc. (QTTB) | Disposition to Issuer | 12,767 | n/a |
| Aug 14, 2024 | Q32 Bio Inc. (QTTB) | Grant/Award | 2,569 | $34.5K |
| Jun 7, 2024 | Aerovate Therapeutics, Inc. (AVTE) | Grant/Award | 12,500 | n/a |
| Apr 11, 2024 | Aerovate Therapeutics, Inc. (AVTE) | Sale | 11,882 | $334.5K |
| Mar 27, 2024 | Q32 Bio Inc. (QTTB) | Grant/Award | 12,767 | n/a |
| Jan 4, 2024 | Aerovate Therapeutics, Inc. (AVTE) | Grant/Award | 3,186 | $43.0K |
| Jun 8, 2023 | Aerovate Therapeutics, Inc. (AVTE) | Grant/Award | 12,500 | n/a |